ClinicalTrials.Veeva

Menu

The CircumVent Project: A CPAP/O2 Helmet Solution for Non-Invasive Ventilation Among Patients With COVID-19

New York University (NYU) logo

New York University (NYU)

Status

Unknown

Conditions

COVID-19 Respiratory Infection
SARS-CoV-2 Acute Respiratory Disease

Treatments

Device: CPAP helmet
Other: Standard of care non-helmet based CPAP ventilation

Study type

Interventional

Funder types

Other

Identifiers

NCT04929691
CDC Foundation Award 1085.1

Details and patient eligibility

About

The purpose of the CircumVent Project is to evaluate the feasibility, adaptability and acceptability of a CPAP/O2 helmet solution for non-invasive ventilation among patients with COVID-19 and health workers in eight COVID-19 treatment and isolation centers in Nigeria.

Full description

Acute respiratory failure, a major cause of death in COVID-19, is managed with high-flow oxygen therapy via invasive mechanical ventilation. In resource-limited settings like Nigeria the shortage of ventilators and oxygen supply make this option challenging. Evidence-based non-invasive alternatives to mechanical ventilation such as the use of continuous positive airway pressure (CPAP) devices exist, but there have been concerns that non-invasive ventilation may expose healthcare workers to infection from aerosolized dispersion of SARS-CoV-2. The investigators propose to evaluate the feasibility, adaptability and acceptability of a CPAP/O2 helmet solution for non-invasive ventilation among patients with COVID-19 and health workers in eight COVID-19 treatment and isolation centers in Nigeria.

The study will occur in 4 stages: 1) Convene a Steering Committee of key stakeholders and recruit implementation sites; 2) Use the integrated Promoting Action on Research Implementation in Health Services (i-PARiHS) framework to guide a needs assessment of treatment centers' capacity to use high-flow oxygen therapy to treat COVID-19 patients, and utilize the findings to develop an implementation strategy for use of CPAP/ O2 helmet solution; 3) Build infrastructure to support training and data monitoring processes and to develop implementation protocols to evaluate the adaptability of the strategy for the use of the CPAP/O2 helmet; and 4) Train health workers, distribute a CPAP/O2 helmet solution for non-invasive ventilation, pilot test the implementation strategy, and assess feasibility of its use and acceptability that includes monitoring altered risk of SARS-CoV-2 infection among healthcare workers.

Enrollment

370 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult patients admitted to a study site with respiratory distress and suspected or confirmed COVID-19 infection

Exclusion criteria

  • Patients who do not meet eligibility criteria

Trial design

Primary purpose

Supportive Care

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

370 participants in 2 patient groups

CPAP- Helmet Users
Experimental group
Description:
Patients admitted to a study site with suspected or confirmed COVID-19 and who consented to using the CPAP helmet
Treatment:
Device: CPAP helmet
Non-CPAP helmet users
Active Comparator group
Description:
Patients admitted to a study site with suspected or confirmed COVID-19 but who did not use a CPAP helmet
Treatment:
Other: Standard of care non-helmet based CPAP ventilation

Trial contacts and locations

9

Loading...

Central trial contact

Andre Fenton, PhD; Olugbenga Ogedegbe, MD, MPH

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems